| scholarly article | Q13442814 |
| P50 | author | Monte Willis | Q38322683 |
| P2093 | author name string | Muhammad Abdullah | |
| Jessica M Berthiaume | |||
| P2860 | cites work | Regulatory effects of miR-146a/b on the function of endothelial progenitor cells in acute ischemic stroke in mice. | Q52758959 |
| TRAF6-Mediated SM22α K21 Ubiquitination Promotes G6PD Activation and NADPH Production, Contributing to GSH Homeostasis and VSMC Survival In Vitro and In Vivo. | Q53372809 | ||
| Stump the experts. Extra-mammary Paget's disease in the perianal region | Q68455317 | ||
| Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism | Q80358575 | ||
| Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts | Q84504327 | ||
| Effect of aerobic exercise on miRNA-TLR4 signaling in atherosclerosis | Q85718725 | ||
| Pioglitazone inhibits angiotensin II-induced atrial fibroblasts proliferation via NF-κB/TGF-β1/TRIF/TRAF6 pathway | Q87649060 | ||
| Identification of the receptor component of the IkappaBalpha-ubiquitin ligase | Q22008569 | ||
| Selective inhibition of BET bromodomains | Q24301009 | ||
| The LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinase Czeta/p62/TRAF6 signaling complex | Q24301337 | ||
| Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition | Q24337006 | ||
| The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL | Q24654977 | ||
| The emerging role of Toll-like receptor 4 in myocardial inflammation | Q26745749 | ||
| Innate immunity and cardiomyocytes in ischemic heart disease | Q27003911 | ||
| A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling | Q27316099 | ||
| Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activation | Q27321637 | ||
| Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor | Q28082430 | ||
| Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes | Q28236619 | ||
| Ubiquitination and degradation of the inhibitors of NF-kappaB | Q28274205 | ||
| TRAF6 is a signal transducer for interleukin-1 | Q28291934 | ||
| TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling | Q28513445 | ||
| Tolerance, danger, and the extended family | Q29547532 | ||
| Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study | Q29614968 | ||
| Cardiac hypertrophy: the good, the bad, and the ugly | Q29615247 | ||
| 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) | Q29617334 | ||
| Role of Adaptive Immunity in the Development and Progression of Heart Failure: New Evidence. | Q30234104 | ||
| Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation. | Q30849102 | ||
| Myocardial dysfunction in sepsis: a large, unsolved puzzle | Q33353302 | ||
| Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling | Q33620139 | ||
| MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6. | Q33648129 | ||
| Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile | Q33656103 | ||
| The role of neutrophils in myocardial ischemia-reperfusion injury | Q33806223 | ||
| Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism | Q33902374 | ||
| Ablation of Akt2 protects against lipopolysaccharide-induced cardiac dysfunction: role of Akt ubiquitination E3 ligase TRAF6. | Q33969148 | ||
| Tumor necrosis factor receptor associated factor 6 is not required for atherogenesis in mice and does not associate with atherosclerosis in humans | Q33996260 | ||
| Extracellular histones are major mediators of death in sepsis | Q34019901 | ||
| TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. | Q34272380 | ||
| Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association | Q34505315 | ||
| A20 Ameliorates Intracerebral Hemorrhage-Induced Inflammatory Injury by Regulating TRAF6 Polyubiquitination. | Q34547536 | ||
| Inflammatory mediators and the failing heart: past, present, and the foreseeable future | Q35011415 | ||
| Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury | Q35175597 | ||
| Toll-like receptors and myocardial inflammation | Q35240118 | ||
| Toll-like receptors in cerebral ischemic inflammatory injury | Q35416110 | ||
| Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects | Q35548721 | ||
| Discovery of small molecule CD40-TRAF6 inhibitors | Q35549406 | ||
| Role of extracellular histones in the cardiomyopathy of sepsis. | Q35555107 | ||
| Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity | Q35575421 | ||
| Function and mechanism of toll-like receptors in cerebral ischemic tolerance: from preconditioning to treatment | Q35575846 | ||
| Sepsis-induced cardiomyopathy | Q35687065 | ||
| Hypertrophy of the heart: a new therapeutic target? | Q35739349 | ||
| Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both? | Q35761448 | ||
| Attenuation of Cardiac Dysfunction in Polymicrobial Sepsis by MicroRNA-146a Is Mediated via Targeting of IRAK1 and TRAF6 Expression | Q35815694 | ||
| Rosuvastatin Attenuates CD40L-Induced Downregulation of Extracellular Matrix Production in Human Aortic Smooth Muscle Cells via TRAF6-JNK-NF-κB Pathway | Q36000924 | ||
| Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins | Q36088932 | ||
| BET protein inhibition mitigates acute myocardial infarction damage in rats via the TLR4/TRAF6/NF-κB pathway | Q36334841 | ||
| TNF receptor-associated factor 6 (TRAF6) mediates the angiotensin-induced non-canonical TGF-β pathway activation of c-kit(+) cardiac stem cells | Q36420224 | ||
| SR-A deficiency reduces myocardial ischemia/reperfusion injury; involvement of increased microRNA-125b expression in macrophages | Q36501225 | ||
| Circulating histones are mediators of trauma-associated lung injury. | Q36605094 | ||
| TRAF molecules in cell signaling and in human diseases | Q36972287 | ||
| The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling. | Q36974840 | ||
| Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view | Q36990515 | ||
| Molecular biology and pathogenesis of viral myocarditis | Q37014831 | ||
| You spin me round: MaFBx/Atrogin-1 feeds forward on FOXO transcription factors (like a record). | Q37072299 | ||
| A20: central gatekeeper in inflammation and immunity | Q37325315 | ||
| Diagnosis and treatment of viral myocarditis | Q37406711 | ||
| Limb Remote Ischemic Postconditioning Reduces Ischemia-Reperfusion Injury by Inhibiting NADPH Oxidase Activation and MyD88-TRAF6-P38MAP-Kinase Pathway of Neutrophils | Q37534516 | ||
| The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology | Q37567071 | ||
| The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls | Q37870040 | ||
| Signaling in innate immunity and inflammation | Q37980557 | ||
| Regulation of NF-κB by ubiquitination and degradation of the IκBs | Q37995680 | ||
| Cell type-specific function of TAK1 in innate immune signaling | Q38105722 | ||
| Combination of statin plus renin angiotensin system inhibition for the prevention or the treatment of atherosclerotic cardiovascular disease | Q38222290 | ||
| Role of innate and adaptive immune mechanisms in cardiac injury and repair | Q38329556 | ||
| Anti-inflammatory therapies for atherosclerosis | Q38349757 | ||
| Innate immunity and the failing heart: the cytokine hypothesis revisited | Q38393039 | ||
| Manual evaluation of tissue microarrays in a high-throughput research project: The contribution of Indian surgical pathology to the Human Protein Atlas (HPA) project | Q38691192 | ||
| Endurance training prevents TWEAK but not myostatin-mediated cardiac remodelling in cancer cachexia | Q39062010 | ||
| The extracellular matrix in myocardial injury, repair, and remodeling. | Q39275058 | ||
| Potential medications or compounds acting on toll-like receptors in cerebral ischemia | Q39344487 | ||
| Ischemic Preconditioning-Induced SOCS-1 Protects Rat Intestinal Ischemia Reperfusion Injury via Degradation of TRAF6. | Q39476992 | ||
| TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer. | Q39532727 | ||
| Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response | Q40217414 | ||
| MicroRNA-125b Prevents Cardiac Dysfunction in Polymicrobial Sepsis by Targeting TRAF6-Mediated Nuclear Factor κB Activation and p53-Mediated Apoptotic Signaling | Q40523308 | ||
| miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency | Q41049761 | ||
| Association of Genes Variants in RANKL/RANK/OPG Signaling Pathway with the Development of Osteonecrosis of the Femoral Head in Chinese Population | Q41454787 | ||
| Association Between TRAF6 Gene Polymorphisms and Susceptibility of Ischemic Stroke in Southern Chinese Han Population | Q41723347 | ||
| Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation | Q41862491 | ||
| Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels | Q43044147 | ||
| Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis: a prospective study | Q44420694 | ||
| Cezanne regulates inflammatory responses to hypoxia in endothelial cells by targeting TRAF6 for deubiquitination. | Q45903931 | ||
| Paying for the Tolls: The High Cost of the Innate Immune System for the Cardiac Myocyte | Q46071506 | ||
| Silencing of Pellino1 improves post-infarct cardiac dysfunction and attenuates left ventricular remodelling in mice | Q46101719 | ||
| Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload | Q46557239 | ||
| Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses. | Q47614555 | ||
| Danger signals: Chemotherapy enhancers? | Q47659090 | ||
| Hypoxia-induced microRNA-146a represses Bcl-2 through Traf6/IRAK1 but not Smad4 to promote chondrocyte autophagy | Q48933369 | ||
| Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. | Q50335804 | ||
| Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus. | Q50768702 | ||
| Di-(2-ethylhexyl) phthalate suppresses IL-12p40 production by GM-CSF-dependent macrophages via the PPARα/TNFAIP3/TRAF6 axis after lipopolysaccharide stimulation. | Q50910067 | ||
| Inflammatory responses involving tumor necrosis factor receptor-associated factor 6 contribute to in-stent lesion formation in a stent implantation model of rabbit carotid artery. | Q51252167 | ||
| Conditional targeting of tumor necrosis factor receptor-associated factor 6 reveals opposing functions of Toll-like receptor signaling in endothelial and myeloid cells in a mouse model of atherosclerosis. | Q51314258 | ||
| Shenqi fuzheng injection improves cvb3-induced myocarditis via inhibiting traf6 expression. | Q51832050 | ||
| The outcome of coxsackievirus B3-(CVB3-) induced myocarditis is influenced by the cellular immune status. | Q52540037 | ||
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 48-61 | |
| P577 | publication date | 2017-11-07 | |
| P1433 | published in | Translational Research | Q15761127 |
| P1476 | title | Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all. | |
| P478 | volume | 195 |
| Q58728912 | Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy |
| Q64911219 | HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies. |
| Q98726639 | MicroRNA sequences modulating inflammation and lipid accumulation in macrophage "foam" cells: Implications for atherosclerosis |
Search more.